Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).

被引：0
|
作者：
Spanu, A
Schillaci, O
Falchi, A
Marongiu, P
Pisu, N
Madeddu, G
Solinas, ME
Solinas, P
Scopinaro, F
Madeddu, G
机构：
[1] Univ Sassari, I-07100 Sassari, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Roma La Sapienza, Rome, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1206
引用
收藏
页码：299P / 299P
页数：1
相关论文
共 50 条
  • [41] Contribution of 111In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours
    Sainz-Esteban, Aurora
    Olmos, Roberto
    Gonzalez-Sagrado, Manuel
    Luisa Gonzalez, Maria
    Angeles Ruiz, Maria
    Garcia-Talavera, Paloma
    Gamazo, Claudia
    Gabriel Villanueva, Juan
    Cobo, Amparo
    de Luis, Daniel
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (03) : 251 - 259
  • [42] Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors
    Krausz, Y
    Bar-Ziv, J
    de Jong, RBJ
    Ish-Shalom, S
    Chisin, R
    Shibley, N
    Glaser, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (01): : 66 - 70
  • [43] Recommended parameters for pathology reporting of gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
    Rasheed, Imran
    Meng, Looi Lai
    Talib, Arni
    MALAYSIAN JOURNAL OF PATHOLOGY, 2018, 40 (01) : 79 - 82
  • [44] SPECT/CT in the neuroendocrine tumours (NET) assessment by means of 111InOctreotide somatostatin receptors scintigraphy (SRS)
    Dore, F.
    Di Russo, C.
    de Denaro, M.
    Mucci, M.
    Cattin, L.
    Piscopello, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S279 - S279
  • [45] Is There an Additional Value of Somatostatin Receptor Subtype 2A Immunohistochemistry Over Somatostatin Receptor Scintigraphy in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
    Van Adrichem, R.
    Kamp, K.
    Van Deurzen, C.
    Biermann, K.
    Feelders, R. A.
    Kwekkeboom, D.
    Hofland, L. J.
    De Herder, W.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 135 - 135
  • [46] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
    Garcia-Carbonero, Rocio
    Salazar, Ramon
    Sevilla, Isabel
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08): : 545 - 551
  • [47] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
    Rocío García-Carbonero
    Ramón Salazar
    Isabel Sevilla
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 545 - 551
  • [48] Somatostatin receptor scintigraphy in neuroendocrine tumours - Is single photon emission tomography (SPECT) required?
    Chow, A
    Caplin, ME
    Buscombe, JR
    Hilson, AJW
    GUT, 2001, 48 : A50 - A50
  • [49] Targeting somatostatin receptors in gastroenteropancreatic neuroendocrine tumours (GEPNETs): Which radiotracers for which tumours?
    Cuny, T.
    Saveanu, A.
    Taieb, D.
    Barlier, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (05): : 310 - 317
  • [50] SOMATOSTATIN-RECEPTOR IMAGING OF NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS
    SCHERUBL, H
    BADER, M
    FETT, U
    HAMM, B
    SCHMIDTGAYK, H
    KOPPENHAGEN, K
    DOP, FJ
    RIECKEN, EO
    WIEDENMANN, B
    GASTROENTEROLOGY, 1993, 105 (06) : 1705 - 1709
12345